WASHINGTON, June 18, 2019 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), today announced that
it will deliver a corporate presentation at the JMP Securities Life
Sciences Conference in New York
City on Wednesday, June 19,
2019 at 2:00 p.m. Eastern
Time.
The corporate presentation at the JMP Securities Life Sciences
Conference will be available live on Vanda's corporate website,
where it also will be archived for 30 days. To access the
presentation, go to Vanda's website at www.vandapharma.com and
click on the Presentations tab on the Investor Relations page.
Please connect to the website several minutes prior to the start of
the live presentation.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the
development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda, please visit www.vandapharma.com.
Company Contact:
Jim
Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
View original
content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-present-at-the-jmp-securities-life-sciences-conference-300870400.html
SOURCE Vanda Pharmaceuticals Inc.